sm04755
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2014 (NCT02191761)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Protein Wnt-3aINHIBITOR
WNT3A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- sm04755
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03502434 | Phase 1 | Sep 11, 2017 | Biosplice Therapeutics |
| NCT03229291 | Phase 1 | Nov 3, 2016 | Biosplice Therapeutics |
| NCT02191761 | Phase 1 | Jun 1, 2014 | Biosplice Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biosplice Therapeutics | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1